Psychiatr. pro Praxi, 2009; 10(5): 209-215

Mixed episode in bipolar affective disorder and its treatment

MUDr. Klára Látalová Ph.D3, doc. MUDr. Ján Praško CSc1,3,2,4, MUDr. Radim Kubínek3, MUDr. Erik Herman5,7,6, MUDr. Pavel Doubek5
1 Psychiatrické centrum Praha, 3. LF UK, Praha
2 Centrum neuropsychiatrických studií, Praha
3 Psychiatrická klinika FN a LF UP, Olomouc
4 3. LF UK, Praha
5 Psychiatrická klinika 1. LF UK a VFN Praha
6 Neurologické oddělení, neuropsychiatrické a epileptologické centrum, Nemocnice Na Františku s poliklinikou, Praha
7 Psychiatrická ambulance, Praha

Mixed epizodes are characterized by the mixture of depressive and manic symptoms. This state experience almost half of bipolar patiens.

Manic symptoms in mixed states usually are dysphoric, with irritability, anxiety, or unpleasant activation. Such states can be difficult to

distinguish from ultradian cycling, in which moods change so rapidly that they seem to blend into each other. Mixed states of bipolarity

represent a generally more difficult phase of the illness to treat with any medication. Lithium has long been considered as less than ideal

in the management of mixed states in bipolar disorder. Valproate and carbamazepine have strong evidence for effectiveness in mixed

mania. Some second generation antipsychotics (olanzapine, aripiprazole, ziprasidone, risperidone) have evidence of effectiveness in

acute treatment and some (olanzapin, quetiapin) in profylaxis. Lamotrigine has been established as ineffective in mixed epizodes.

Keywords: mixed states, bipolar affective disorder, antipsychotic agents, antidepressants, mood stabilizers.

Published: November 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Látalová K, Praško J, Kubínek R, Herman E, Doubek P. Mixed episode in bipolar affective disorder and its treatment. Psychiatr. praxi. 2009;10(5):209-215.
Download citation

References

  1. Leonhard K, Berman R (trans.), Robins E (ed): The Classification of Endogenous Psychoses, 5th editon, Irvington Publishing, New York, USA 1979 (Originally published in 1957, Aufteilung de Endogenen Psychosen. Akademie-Verlag, Berlin).
  2. Bleuler E, Brill AA. Textbook of Psychiatry, 4th editon. Macmillan, New York, USA 1924.
  3. Levitt J a Tsuang M. The heterogenity of schizoaffective disorders: Implications for treatment. Am J Psychiatry 1988; 145: 926-936. Go to original source... Go to PubMed...
  4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition (Rev.). APA, Washington, DC, USA, 2000.
  5. 10. Mezinárodní klasifikace nemocí - 10. revize, MKN-10, Maxdorf Praha 1996: 503 s.
  6. Bauer MS. Mood disorder: Bipolar (manic-depressive disorders). In: Tasman A, Kay J, Lieberman JA, First MB, Maj M: Psychiatry. 3rd Ed. Wiley-Blackwell, Chichester 2008: 1335-1378. Go to original source...
  7. Bauer MS, Crits-Christoph P, Ball W, et al. Independent assessment of manic and depressive symptoms by self-rating scale: Characteristics and implications for the study of mania. Arch Gen Psychiatry 1991; 48: 807-812. Go to original source... Go to PubMed...
  8. Bauer MS, Whybrow P, Gyulai L, at al. Testing definition of dysphoric mania and hypomania: prevalence, clinical characteristics, and interepisode stability. J Affective Dis 1994; 32: 201-211. Go to original source... Go to PubMed...
  9. Benazzi F. Depressive mixed state: a feature of the natural course of bipolar II (and major depressive disorder) Psychopathology 2004; 37: 207-212.
  10. Zhang HW, Wisniewski, S, Bauer M, et al. Comparison of quality of life across mood states in bipolar disorder. Data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder participants. Comprehensive Psychiatry 2006; 47: 161-168. Go to original source... Go to PubMed...
  11. Isometsa ET, Henriksson MM, Aro HM, et al. Suicide in bipolar disorder in Finland. Am J Psychiatry 1994; 151: 1020-1024. Go to original source... Go to PubMed...
  12. Goldberg JF, McElroy SL. Bipolar mixed episodes: characteristics and comorbidities. J Clin Psychiatry 2007; 68(suppl. 10): 25-30. Go to original source... Go to PubMed...
  13. McElroy SL, Keck PE Jr, Pope GH, Hudson J, Faedda G, Swann A. Clinical and reseach implications of the diagnosis of dysphoric or mixed mania or hypomania. American Journal of Psychiatry 1992; 149: 1633-1644. Go to original source... Go to PubMed...
  14. Akiskal HS, Hantouche EG, Bourgeois ML, et al. Temperament, and the clinical picture in dysforic mania: fundungs from French national study (EPIMAN) - Journal of Affective Disorders 1998; 50: 175-186. Go to original source... Go to PubMed...
  15. Arnold LM, Mc Elroy SL, Keck PE Jr. The role of gender in mixed mania. Comprehensive Psychiatry 2000; 41: 83-87. Go to original source... Go to PubMed...
  16. Benazzi F. Which could be a clinically useful definition of depressive mixed state? Progress in Neuro. Psychopharmacology and Biological Psychiatry 2002; 42: 461-465. Go to original source... Go to PubMed...
  17. American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder. Am. J. Psychiatry 2002; 159(Suppl): 1-50.
  18. Sachs GS, Printz DJ, Kahn DA, et al. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder. Postgrad. Med. Special Issue 2000; 1: 1-104.
  19. Češková E, et al. Bipolární afektivní porucha in: Doporučené postupy v psychiatrické péči II. 1. vydání, Infopharm, 2006: 204 s.
  20. Swann AC, Bowden CL, Morris D, et al. Depression during mania: treatment response to lithium or divalproex. Arch Gen Psychiatry 1997; 54: 37-42. Go to original source... Go to PubMed...
  21. Bowden CL, Davis J, Morris D, et al. Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania. Depress Anxiety 1997; 6(suppl 1): 26-30. Go to original source... Go to PubMed...
  22. Greil W, Kleindienst N, Erazo N, Muller-Oerlinghausen B. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 1998; 18: 455-460. Go to original source... Go to PubMed...
  23. Greil W, Ludwig-Mayerhofer W, Erazo N, et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders-a randomised study. J Affect Disord 1997; 43: 151-161. Go to original source... Go to PubMed...
  24. Suppes T, Vieta E, Liu S, Brecher M, Paulsson B. Trial 127 Investigators. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry 2009; 166: 476-488. Go to original source... Go to PubMed...
  25. Tohen M, Chengappa KN, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry, 2002; 59: 62-69. Go to original source... Go to PubMed...
  26. Vieta E, Suppes T, Eggens I, et al. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 2008; 109: 251-263. Go to original source... Go to PubMed...
  27. Vieta E, T'joen C, McQuade RD, et al. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. Am J Psychiatry 2008; 165: 1316-1325. Go to original source... Go to PubMed...
  28. Bowden CL, Calabrese JR, Sachs G, et al. Lamictal 606 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry, 2003; 60(suppl 4): 392-400. Go to original source... Go to PubMed...
  29. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149: 108-111. Go to original source... Go to PubMed...
  30. Sachs GS, Collins MC. A placebo-controlled trial of divalproex sodium in acute bipolar depression. Program and abstracts of the 40th Annual Meeting of the American College of Neuropsychopharmacology; December 9-13, 2000; Waikoloa, Hawaii.
  31. Calabrese JR, Shelton MD, Rapport DJ, Kimmel SE. Bipolar disorders and the effectiveness of novel anticonvulsants. J Clin Psychiatry 2002; 63(suppl 3):5-9.
  32. Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 1992; 12(1 suppl 1):53-56. Go to original source... Go to PubMed...
  33. Tohen M, Chengappa KN, Suppes T, et al. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry 2004; 184: 337-345. Go to original source... Go to PubMed...
  34. Weisler RH, Kalali AH, Ketter TA; SPD417 Study Group. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65(suppl 4): 478-484. Go to original source... Go to PubMed...
  35. Tohen M, Jacobs TG, Grundy SL, et al. (Olanzapine HGGW Study Group): Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2000; 57: 841-849. Go to original source... Go to PubMed...
  36. Tohen M, Sanger TM, McElroy SL, et al. (Olanzapine HGEH Study Group): Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999; 156: 702-709. Go to original source... Go to PubMed...
  37. Sanger TM, Tohen M, Vieta E, et al. Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. J Affect Disorders 2002; 73: 155-161. Go to original source... Go to PubMed...
  38. Perlis RH, Baker RW, Zarate CA Jr, et al. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. J Clin Psychiatry 2006; 67: 1747-1753. Go to original source... Go to PubMed...
  39. Tohen M, Greil W, Calabrese JR, et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005; 162: 1281-1290. Go to original source... Go to PubMed...
  40. Keck PE, Versiani M, Potkin S, et al. Ziprasidone in Mania Study Group. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003; 160: 741-785. Go to original source... Go to PubMed...
  41. Potkin SG, Keck PE, Segal S, et al. Ziprasidone in acute bipolar mania. A 21-day randomized, double-blind, placebo-controlled replication study. J Clin Psychopharmacol 2005; 25: 301-310. Go to original source... Go to PubMed...
  42. Ramey TS, Giller EL, English P, et al. Efficacy and tolerability of ziprasidone in acute bipolar mania: 12 week double blind study (Abstract). Biol Psychiatry 2005; Suppl 5: 535.
  43. Weisler RH, Dunn J, English P. Ziprasidone in adjunctive treatment of acute bipolar mania: A randomized, doubleblind placebo-controlled Trial. 16th Congress of the European College of Neuropsychopharmacology (ECNP), Prague, Czech Republic, 20-24 Sep 2003. Eur Neuropsychopharmacol 13(suppl 4): 344-345. Go to original source...
  44. Keck PE Jr, Versiani M, Warrington L, Loebel AD, Horne RL. Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania, 2009; 70: 844-851. Go to original source... Go to PubMed...
  45. Sachs G, Sanchez R, Marcus R, et al. Aripiprazole Study Group. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol 2006; 20: 536-546. Go to original source... Go to PubMed...
  46. Keck PE Jr, Marcus R, Tourkodimitris S, et al. A placebocontrolled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003; 160: 1651-1658. Go to original source... Go to PubMed...
  47. Keck PE, Orsulak PJ, Cutler AJ, et al. CN138-135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. J Affect Disord. 2009; 112: 36-49. Go to original source... Go to PubMed...
  48. Suppes T, Eudicone J, McQuade R, Pikalov A, Carlson B. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. J Affect Disord 2008; 107: 145-154. Go to original source... Go to PubMed...
  49. Young AH, Oren DA, Lowy A, et al. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. Br J Psychiatry 2009; 194: 40-48. Go to original source... Go to PubMed...
  50. Keck PE Jr, Calabrese JR, McIntyre RS, et al. Aripiprazole Study Group. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 2007; 68: 1480-1491. Go to original source... Go to PubMed...
  51. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159(7): 1146-1154. Go to original source... Go to PubMed...
  52. Vieta E, Goikolea JM, Corbella B, et al. Group for the Study of Risperidone in Affective Disorders (GSRAD). Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry 2001; 62(10): 818-825. Erratum in: J Clin Psychiatry 2002; 63: 79. Go to original source... Go to PubMed...
  53. Valentí M, Benabarre A, García-Amador M, et al. Electroconvulsive therapy in the treatment of mixed states in bipolar disorder. Eur Psychiatry 2008; 23: 53-56. Go to original source... Go to PubMed...
  54. Fink M. ECT in therapy-resistant mania: does it have a place? Bipolar Disord 2006; 8(suppl 3): 307-309. Go to original source... Go to PubMed...
  55. Sienaert P, Peuskens J. Electroconvulsive therapy: an effective therapy of medication-resistant bipolar disorder. Bipolar Disord 2006; 8(3): 304-306. Go to original source... Go to PubMed...
  56. Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 1988; 45: 727-732. Go to original source... Go to PubMed...
  57. Volpe FM, Tavares A. Impact of ECT on duration of hospitalizations for mania. J ECT 2003; 19: 17-21. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.